Acellular Exponential Or Geometric Amplification (e.g., Pcr, Etc.) Patents (Class 435/91.2)
-
Patent number: 9689031Abstract: The invention is in general directed to the rapid exponential amplification of short DNA or RNA sequences at a constant temperature.Type: GrantFiled: July 14, 2007Date of Patent: June 27, 2017Assignee: Ionian Technologies, Inc.Inventors: Brian K. Maples, Rebecca C. Holmberg, Andrew P. Miller, Jarrod W. Provins, Richard B Roth, Jeffrey G. Mandell
-
Patent number: 9683255Abstract: The present invention concerns a method for activating a nucleic acid for a polymerase reaction with the steps: (a) Heating a nucleic acid to a temperature of 55° C. to 80° C., (b) cooling the nucleic acid to a temperature at which a polymerase shows no substantial decrease in activity, and (c) starting the polymerase reaction by the addition of a heat-labile polymerase to the nucleic acid.Type: GrantFiled: September 11, 2006Date of Patent: June 20, 2017Assignee: QIAGEN GMBHInventors: Christian Korfhage, Dirk Löffert
-
Patent number: 9670243Abstract: Embodiments relate to methods of sequencing nucleic acids. Embodiments encompass the use of nucleotide analogs and a nucleic acid polymerase enzyme or enzyme complex comprising proofreading activity. The nucleotide analogs may become incorporated into a replicating strand and induce the proofreading activity of the polymerizing enzyme, thereby prolonging the duration of a signal associated with nucleotide incorporation, resulting in more observable sequencing events and increasing the accuracy of nucleic acid sequencing.Type: GrantFiled: May 27, 2011Date of Patent: June 6, 2017Assignee: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTEInventors: Chung-Fan Chiou, Chao-Chi Pan, Jenn-Yeh Fann, Shang-Chia Chang, Tsu-Ju Fu
-
Patent number: 9652585Abstract: A method for determining the presence of a copy number imbalance in genomic DNA of a test sample is provided. The method can separately measure hybridization of a single test sample to a first hybridization array and hybridization of a plurality of reference samples to a plurality of other, respective test arrays. A determination of copy number can be based on the best fit reference array, relative to the test array. The best fit can be determined based on the closest or most similar signal-to-noise ratio of the measured signals.Type: GrantFiled: March 16, 2010Date of Patent: May 16, 2017Assignee: BLUEGNOME LIMITEDInventors: Andrew Craig, Anthony Brown, Nicholas Haan
-
Patent number: 9650629Abstract: Disclosed is a process for clonal pre-amplification of a nucleic acid involving the steps of (i) providing a plurality of different nucleic acid molecules (b) attaching adaptor sequences to the 3? ends and 5? ends of the nucleic acid molecules (c) preparing a water in oil emulsion wherein the majority of water droplets comprises one or none member of the plurality of different nucleic acid molecules (d) clonally amplifying the plurality of different nucleic acid molecules. In particular, the different nucleic acid molecules are mRNA molecules.Type: GrantFiled: June 27, 2011Date of Patent: May 16, 2017Assignee: Roche Molecular Systems, Inc.Inventors: Thomas Froehlich, Tobias Heckel
-
Patent number: 9644199Abstract: The present invention provides a simple and rapid method for preparing purified transposase complexes that are highly suited for fragmenting DNA. The method includes forming transposase complexes with oligonucleotide adapters in cell lysate, then purifying the complexes from the other substance in the cell lysate. Purification is accomplished using a specific binding pair, in which one member of the pair is bound to an oligonucleotide adapter of the complex and the other member of the pair is bound to a solid substrate. The bound complexes can be immediately used in DNA fragmentation reactions to produce solid substrate-bound DNA fragments, which can be used for any number of purposes, including as templates for amplification and sequencing.Type: GrantFiled: August 7, 2013Date of Patent: May 9, 2017Assignee: Agilent Technologies, Inc.Inventor: Alexander S Belyaev
-
Patent number: 9644235Abstract: The invention provides an assay method for detection and/or quantification of a plurality of nucleic acid or protein targets in a sample. In the method probes are used to associate a detectable tag sequence with each of the selected targets present in the sample. Probes or primers sufficient to identify at least 25, and preferably at least 500, different targets are used. The method involves segregating aliquots of the sample from each other and detecting the tag sequences in each aliquot.Type: GrantFiled: July 27, 2015Date of Patent: May 9, 2017Assignee: Fluidigm CorporationInventors: Michael Lucero, Marc Unger
-
Patent number: 9631230Abstract: The invention provides methods of conducting a nucleic acid reaction, including methods for performing digital PCR using a “droplet-in-oil” technology. In the methods, the starting sampled is segmented at least partially into a set of sample droplets each containing on average about one or fewer copies of a target nucleic acid. The droplets are passed in a continuous flow of immiscible carrier fluid through a channel that passes through a thermal cycler, whereby the target is amplified. In one implementation, the droplets are about 350 nl each and the number of positively amplified droplets is counted at the near-saturation point.Type: GrantFiled: August 11, 2009Date of Patent: April 25, 2017Assignee: STOKES BIO LTDInventors: Mark Davies, Tara Dalton
-
Patent number: 9631233Abstract: The present invention provides methods to obtain dry compositions of reaction compounds that maintain the biological activity of the compounds upon re-solubilization after a certain storage time. Preferably, the dry composition comprises a polymerase, and the dry composition is usable for polymerase chain reaction (PCR) amplification after re-solubilization.Type: GrantFiled: September 16, 2015Date of Patent: April 25, 2017Assignee: Roche Diagnostics Operations, Inc.Inventors: Thomas Metzler, Tobias Haslinger, Annette Peceny, Harald Sobek
-
Patent number: 9617588Abstract: Polymorphisms are present throughout an organism's genome, and understanding which alleles are present in a particular organism's genome can be advantageous. When probing the identity of these alleles, one must minimize incorrect readings due to inefficiencies in the system. In hydrolysis probe applications, these inefficiencies may be due to over-activity of an exonuclease functionality that excises nucleotides from probes that are only partially, complementary to a region of a target. The present invention provides a mixture that contains a plurality of polymerases including one that has a 5??3? exonuclease functionality and one that lacks or substantially lacks it, each in a sufficient relative amount and concentration to increase efficiencies of the system.Type: GrantFiled: October 4, 2011Date of Patent: April 11, 2017Assignee: Thermo Fisher Scientific Baltics UABInventor: Jaakko Kurkela
-
Patent number: 9617586Abstract: The invention is in general directed to the rapid exponential amplification of short DNA or RNA sequences at a constant temperature.Type: GrantFiled: July 14, 2008Date of Patent: April 11, 2017Assignee: Ionian Technologies, Inc.Inventors: Brian K. Maples, Rebecca C. Holmberg, Andrew P. Miller, Jarrod Provins, Richard B. Roth, Jeffrey Mandell
-
Patent number: 9598724Abstract: Disclosed are methods for multiple displacement amplification of a nucleic acid sequence in a sample. The nucleic acid is contacted with a reaction mixture that includes a set of oligonucleotide primers and a plurality of polymerase enzymes. The reaction mixture is subjected to conditions under which the nucleic acid sequence is amplified to produce an amplification product in a multiple displacement amplification reaction. Also disclosed are kits containing a set of oligonucleotide primers with random sequences having lengths of 6 to 8 nucleobases. At least some of the individual members of the primers have one or more ribose modifications that stabilize or lock the ribose ring in a 3? -endo conformation. At least some of the primers have one or more universal nucleobases.Type: GrantFiled: May 30, 2008Date of Patent: March 21, 2017Assignee: IBIS BIOSCIENCES, INC.Inventors: David D. Duncan, Mark W. Eshoo
-
Patent number: 9593369Abstract: The present disclosure provides methods, systems, and apparatuses for collecting and/or amplifying nucleic acids. In general, provided methods, systems, and apparatuses involve contacting a sample including a nucleic acid with a nucleic acid amplification reagent without purification of nucleic acids from the sample.Type: GrantFiled: October 4, 2012Date of Patent: March 14, 2017Assignee: Spartan Bioscience Inc.Inventors: Kelly Jackson, Chris Harder, Adam Michael Damry, Paul Lem
-
Patent number: 9593328Abstract: A nucleic acid molecule can be annealed to an appropriate immobilized primer. The primer can then be extended and the molecule and the primer can be separated from one another. The extended primer can then be annealed to another immobilized primer and the other primer can be extended. Both extended primers can then be separated from one another and can be used to provide further extended primers. The process can be repeated to provide amplified, immobilized nucleic acid molecules. These can be used for many different purposes, including sequencing, screening, diagnosis, in situ nucleic acid synthesis, monitoring gene expression, nucleic acid fingerprinting, etc.Type: GrantFiled: January 20, 2015Date of Patent: March 14, 2017Assignee: Illumina, Inc.Inventors: Eric H. Kawashima, Laurent Farinelli, Pascal Mayer
-
Patent number: 9593383Abstract: Provided are compositions, kits, and methods for the identification of Listeria. In certain aspects and embodiments, the compositions, kits, and methods may provide improvements in relation to specificity, sensitivity, and speed of detection.Type: GrantFiled: May 2, 2014Date of Patent: March 14, 2017Assignee: GEN-PROBE INCORPORATEDInventors: Michael R. Reshatoff, Kristin W. Livezey, James J. Hogan
-
Patent number: 9587263Abstract: Provided herein are methods and kits for isothermal nucleic acid amplifications that use a target nucleic acid template; a reaction mixture comprising a DNA polymerase having a strand displacement activity, a deoxyribonucleoside triphosphate (dNTP) mixture, a primer with a 3? end and a 5? end, a molecular crowding reagent, and a buffer solution for amplifying the target nucleic acid template. The buffer solution maintains a low salt concentration of the reaction mixture, and wherein the salt concentration results in a melting temperature (Tm) of the primer at least 10° C. below the reaction temperature. The amplification is effected under isothermal condition.Type: GrantFiled: March 26, 2014Date of Patent: March 7, 2017Assignee: General Electric CompanyInventors: Ryan Charles Heller, John Richard Nelson, Paresh Lakhubhai Patel, Alison Myfanwy Wakefield, Stephen James Capper
-
Patent number: 9580762Abstract: Methods for detecting flavivirus nucleic acids. Particularly described are methods for detecting West Nile virus nucleic acids in the 3? non-coding region.Type: GrantFiled: May 9, 2014Date of Patent: February 28, 2017Assignee: GEN-PROBE INCORPORATEDInventors: Jeffrey M. Linnen, Reinhold B. Pollner
-
Patent number: 9574230Abstract: Disclosed here is a method for the detection of a naturally occurring mutation in a target sequence in one or more members of a population, comprising: providing a plurality of pools of amplification products each comprising the target sequence amplified from genomic DNA of a subset of the one or more members of the population, wherein each pool of the amplification products shares a unique pool identifier; determining the nucleotide sequence of the amplification products using high throughput sequencing; and identifying mutations by clustering/aligning the sequences of the amplified products without the use of an enzyme which recognizes and cuts single nucleotide sequence mismatches and without performing heteroduplex analysis, and identifying the one or more members carrying the mutation using the pool identifier.Type: GrantFiled: May 26, 2016Date of Patent: February 21, 2017Assignee: KEYGENE N.V.Inventors: Michael Josephus Theresia van Eijk, Adrianus Johannes van Tunen
-
Patent number: 9562250Abstract: A method for replicating and amplifying a target nucleic acid sequence is described. A method of the invention involves the formation of a recombination intermediate without the prior denaturing of a nucleic acid duplex through the use of a recombination factor. The recombination intermediate is treated with a high fidelity polymerase to permit the replication and amplification of the target nucleic acid sequence. In preferred embodiments, the polymerase comprises a polymerase holoenzyme. In further preferred embodiments, the recombination factor is bacteriophage T4 UvsX protein or homologs from other species, and the polymerase holoenzyme comprises a polymerase enzyme, a clamp protein and a clamp loader protein, derived from viral, bacteriophage, prokaryotic, archaebacterial, or eukaryotic systems.Type: GrantFiled: June 24, 2014Date of Patent: February 7, 2017Assignee: The Penn State Research FoundationInventors: Stephen J Benkovic, Frank Salinas
-
Patent number: 9562264Abstract: The invention is in general directed to the rapid exponential amplification of short DNA or RNA sequences at a constant temperature.Type: GrantFiled: October 30, 2013Date of Patent: February 7, 2017Assignee: Ionian Technologies, Inc.Inventors: Brian K Maples, Rebecca C. Holmberg, Andrew P. Miller, Jarrod Provins, Richard Roth, Jeffrey Mandell
-
Patent number: 9551027Abstract: Methods and compositions for the amplification of nucleic acids and generation of concatemers are disclosed. Amplification methods provided herein may be performed under isothermal conditions. Methods and compositions may include reagents such as nucleic acid polymerases and primers.Type: GrantFiled: November 18, 2014Date of Patent: January 24, 2017Assignee: Theranos, Inc.Inventors: Kamila Belhocine, Josephine Lee, Pranav Patel, Aaron Richardson, Scott Tabakman
-
Patent number: 9551039Abstract: The present invention relates to polynucleotides enabling the rapid, simple and specific detection of Group B Streptococcus highly-virulent ST-17 clones. The present invention also relates to the polypeptides encoded by said polynucleotides, as well as to antibodies directed or raised against said polypeptides. The present invention also relates to kits and methods for the specific detection of Group B Streptococcus highly-virulent ST-17 clones, using the polynucleotides, the polypeptides or the antibodies according to the invention.Type: GrantFiled: April 16, 2014Date of Patent: January 24, 2017Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PARIS DESCARTES, ASSISTANCE PUBLIQUE—HOPITAUX DE PARISInventors: Claire Poyart, Marie-Cecile Lamy, Shaynoor Dramsi, Elisabeth Sauvage, Philippe Glaser, Patrick Trieu-Cuot
-
Patent number: 9546389Abstract: The present disclosure provides methods and systems for amplifying nucleic acid samples. In some aspects, the methods and systems described provided can be useful in conducting multiple nucleic acid amplification reactions in parallel. In some embodiments, methods and systems provided herein can be useful in conducting reverse transcription and DNA amplification in parallel. Moreover, in some aspects, the methods and systems described herein can be useful in analysis of nucleic acid samples. In some embodiments, methods and systems provided herein can be useful for conducting multiple series of primer extension reactions, which can aid in analysis of a nucleic acid sample.Type: GrantFiled: December 9, 2015Date of Patent: January 17, 2017Assignee: COYOTE BIOSCIENCE CO., LTD.Inventor: Xiang Li
-
Patent number: 9512487Abstract: There is a need for improved methods for determining the diagnosis and prognosis of patients with conditions, including autoimmune disease and cancer, especially lymphoid neoplasms, such as lymphomas and leukemias. Provided herein are methods for using DNA sequencing to identify personalized, or patient-specific biomarkers in patients with lymphoid neoplasms, autoimmune disease and other conditions. Identified biomarkers can be used to determine and/or monitor the disease state for a subject with an associated lymphoid disorder or autoimmune disease or other condition. In particular, the invention provides a sensitive method for monitoring lymphoid neoplasms that undergo clonal evolutions without the need to development alternative assays for the evolved or mutated clones serving as patient-specific biomarkers.Type: GrantFiled: February 10, 2014Date of Patent: December 6, 2016Assignee: ADAPTIVE BIOTECHNOLOGIES CORP.Inventors: Malek Faham, Thomas Willis
-
Patent number: 9512472Abstract: The invention is directed to methods of removing amplicons of non target and/or target nucleic acid sequences having one or more modified (e.g., methylated) nucleotides from a sample wherein the sample comprises the non target nucleic acid and a target nucleic acid sequence to be amplified.Type: GrantFiled: April 14, 2016Date of Patent: December 6, 2016Assignee: Courtagen Life Sciences, Inc.Inventor: Kevin J. McKernan
-
Patent number: 9499859Abstract: The present invention relates to a method for detecting a circularized single-stranded DNA by means of the isothermal hyperbranched rolling circle amplification technique, in which the primers used comprise a detectable barcode sequence and, optionally, a spacer which blocks polymerization by DNA polymerase. The present invention also relates to the use of said method for detecting a genetic polymorphism of one or more base pair(s).Type: GrantFiled: August 13, 2010Date of Patent: November 22, 2016Inventors: Ulrich Bockelmann, Virgile Viasnoff, Ismaïl Cisse
-
Patent number: 9499814Abstract: The invention provides products of manufacture for screening for compositions that can modify a cell's gene expression profile, and methods for making and using them. In one embodiment, the invention provides products of manufacture and methods comprising a high content, high throughput screening for a composition (e.g., chemicals, small molecules) that can modify a cell's physiology based on the composition's ability to modify the cell's gene expression signature.Type: GrantFiled: January 20, 2011Date of Patent: November 22, 2016Assignee: The Regents of the University of CaliforniaInventor: Xiang-Dong Fu
-
Patent number: 9499860Abstract: A primer and method for amplification of a target nucleic acid, the primer adapted to conform into a conformation that dissociates from a complementary strand of DNA duplex. The conformation may have a free energy with more favorable thermodynamics than a corresponding DNA duplex, such as a B-DNA duplex. The dissociation may occur during an extension step of an amplification method, such as polymerase chain reaction. The method can proceed isothermally, and the primers may include intrinsic fluorescence.Type: GrantFiled: February 18, 2011Date of Patent: November 22, 2016Assignee: The Ohio State UniversityInventor: Besik Kankia
-
Patent number: 9494520Abstract: The invention generally relates to droplet based digital PCR and methods for analyzing a target nucleic acid using the same. In certain embodiments, methods of the invention involve forming sample droplets containing, on average, a single target nucleic acid, amplifying the target in the droplets, excluding droplets containing amplicon from the target and amplicon from a variant of the target, and analyzing target amplicons.Type: GrantFiled: April 19, 2013Date of Patent: November 15, 2016Assignee: Raindance Technologies, Inc.Inventor: Darren R. Link
-
Patent number: 9491916Abstract: Particular aspects provide novel mutant plants and plant parts thereof, derived via mutagenesis, having disease resistance and other useful traits. Particular embodiments provide a wheat genotype ‘RRR Scarlet’ (‘Scarlet-Rz1’), plants and seeds thereof, methods for producing a plant comprising crossing ‘Scarlet-Rz1’ plants with another wheat plant, hybrid wheat seeds and plants produced by crossing ‘Scarlet-Rz1’ plants with another line or plant, and creation of variants by mutagenesis or transformation of ‘Scarlet-Rz1’. Additional aspects provide methods for producing other varieties or breeding lines derived from ‘Scarlet-Rz1’ and to varieties or breeding lines produced thereby. Further aspects provide for mutant plants and plant parts thereof that are resistant and/or tolerant to plant root fungal pathogens such as Rhizoctonia and Pythium. Additional embodiments provide mutant plants and plant parts thereof that exhibit stress tolerance and/or resistance.Type: GrantFiled: February 7, 2007Date of Patent: November 15, 2016Assignees: WASHINGTON STATE UNIVERSITY, UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTUREInventors: Camille Marie Steber, Kimberlee Kae Kidwell, Victor Louis Demacon, Patricia Ann Okubara
-
Patent number: 9493813Abstract: The invention features methods for identifying compounds that modulate the activity of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K). Inhibitors of PI5P4K can be used in, for example, the treatment or prevention of cell proliferation disorders (e.g., the prevention of tumor cell growth in p53 mutated cancers).Type: GrantFiled: January 13, 2012Date of Patent: November 15, 2016Assignee: Beth Israel Deaconess Medical Center, Inc.Inventors: Brooke Emerling, Atsuo Sasaki, Lewis C. Cantley, Jonathan Hurov
-
Patent number: 9487824Abstract: Provided are methods of enrichment and detection of target nucleic acids during target amplification in the presence of excess amounts of highly homologous sequences, the methods having substantial diagnostic utility (e.g., cancer diagnostics). Provided are amplification reaction mixtures having at least one cleavage-directing oligonucleotide, the respective binding sites of which, for the target and homologous sequences, include one or more nucleotide positions differing in sequence between the target homologous sequences.Type: GrantFiled: June 28, 2012Date of Patent: November 8, 2016Inventor: Igor Kutyavin
-
Patent number: 9487825Abstract: Modified nucleic acid adapters are provided that collectively provide a mixture of nucleotides at the 3? end of 5? adapters and at the 5? end of 3? adapters such that at least one adapter in each set has any given nucleotide at position 1, i.e., the nucleotide position available for ligation to a small RNA, and has any given nucleotide at position 2 adjacent to position 1 for use in overcoming bias during nucleic acid manipulation, such as small RNA characterization and/or profiling by, e.g., deep sequencing, along with methods for use of the modified adapters in small RNA characterization. The modified adapters have at least two mixed nucleotides at the adapter terminus to be ligated to a nucleic acid such as a small RNA.Type: GrantFiled: May 14, 2012Date of Patent: November 8, 2016Assignee: MOUNT SINAI SCHOOL OF MEDICINEInventors: Ravi Sachidanandam, Anitha Jayaprakash, Brian Brown
-
Patent number: 9481907Abstract: A two-step multiplex amplification reaction includes a first step which truncates the standard initial multiplex amplification round to “boost” the sample copy number by only a 100-1000 fold increase in the target. Following the first step the product is divided into optimized secondary single amplification reactions, each containing one of the primer sets that were used previously in the first or multiplexed booster step. The booster step can occur using an aqueous target nucleic acid or using a solid phase archived nucleic acid. In particular, nucleic acid sequences that uniquely identify E. Coli were identified using the multiplex amplification method.Type: GrantFiled: June 12, 2014Date of Patent: November 1, 2016Assignee: Applied Biosystems, LLCInventors: John C. Gerdes, Elaine Best, Jeffrey M. Marmaro
-
Patent number: 9476089Abstract: The present invention relates to methods of making linear nucleic acid probes using rolling circle amplification methods. In one aspect, an oligonucleotide template sequence is contacrted with one or more first primers, a first polymerase and first nucleotides under conditions that extend one or more hybridize primers to make a strand complementary to the oligonucleotide template sequence thereby forming a double stranded oligonucleotide. The double stranded oligonucleotide is circularized. A rolling circle template is obtained from the circularized double stranded oligonucleotide. The rolling circle template is contacted with one or more second primers, a second polymerase and second nucleotides under conditions that form a single stranded nucleic acid, and the single stranded nucleic acid is cleaved to form the plurality of nucleic acid probes.Type: GrantFiled: October 18, 2012Date of Patent: October 25, 2016Assignee: President and Fellows of Harvard CollegeInventors: Chao-ting Wu, Brian Beliveau
-
Patent number: 9469872Abstract: Methods for amplifying nucleic acids are provided. The methods can be used to minimize sequence specific bias caused by the preferential amplification of certain nucleic acid sequences. Methods are described which can lower the efficiency of AT rich templates relative to GC rich templates, thereby minimizing GC bias during amplification reactions with multiple templates of different sequence. The methods are suited to solid phase amplification, for example, utilizing flow cells.Type: GrantFiled: June 9, 2014Date of Patent: October 18, 2016Assignee: ILLUMINA CAMBRIDGE LIMITEDInventors: Roberto Rigatti, Jonathan Mark Boutell, Min-Jui Richard Shen
-
Patent number: 9464317Abstract: The present invention provides methods, apparatuses and computer programs for verifying the integrity of a probe by comparing the fluorescence value of a probe to a threshold value. The invention also provides for methods, apparatuses and computer programs for normalizing the fluorescence value of a probe and detecting a target nucleic acid in a sample.Type: GrantFiled: April 26, 2007Date of Patent: October 11, 2016Assignee: CEPHEIDInventors: Stanley H. Sakai, William McMillan
-
Patent number: 9458498Abstract: The present invention pertains to: a method for modifying a nucleic acid contained in a sample, the method including a step for bringing the sample into contact with a nucleic acid-modifying agent in the presence of an acidic polysaccharide and/or a nucleotide; and a method for selectively detecting a nucleic acid derived from living cells contained in the sample, the method including the following steps: (a) a step for modifying a nucleic acid contained in a sample according to the method for modifying a nucleic acid contained in a sample, which includes a step for bringing the sample into contact with a nucleic acid-modifying agent in the presence of an acidic polysaccharide and/or a nucleotide; and (b) a step for selectively detecting an unmodified nucleic acid from the sample after step (a). The present invention further pertains to a kit and composition for use in these methods.Type: GrantFiled: January 20, 2012Date of Patent: October 4, 2016Assignee: TAKARA BIO INC.Inventors: Junko Yamamoto, Keiko Kubo, Takashi Uemori, Hiroyuki Mukai, Kiyozo Asada
-
Patent number: 9453257Abstract: Provided herein are methods, compositions and kits to extract and relatively enrich by physical separation or amplification short base pair nucleic acid in the presence of a high background of genomic material (e.g., host or maternal nucleic acids).Type: GrantFiled: February 14, 2014Date of Patent: September 27, 2016Assignee: SEQUENOM, INC.Inventors: Carolyn R. Hoyal-Wrightson, Andreas Braun, Karsten E Schmidt
-
Patent number: 9441266Abstract: The invention generally relates to droplet based digital PCR and methods for analyzing a target nucleic acid using the same. In certain embodiments, methods of the invention involve forming sample droplets containing, on average, a single target nucleic acid, amplifying the target in the droplets, excluding droplets containing amplicon from the target and amplicon from a variant of the target, and analyzing target amplicons.Type: GrantFiled: February 22, 2013Date of Patent: September 13, 2016Assignee: Raindance Technologies, Inc.Inventors: Jonathan William Larson, Qun Zhong, Darren Roy Link
-
Patent number: 9422586Abstract: A method of rapid, genome and proteome based identification of unknown pathogenic or non-pathogenic organisms in a complex sample. The entire sample is analyzed by creating millions of emulsion encapsulated microdroplets, each containing a single pathogenic or non-pathogenic organism sized particle and appropriate reagents for amplification. Following amplification, the amplified product is analyzed.Type: GrantFiled: June 15, 2007Date of Patent: August 23, 2016Assignee: Lawrence Livermore National Security, LLCInventors: Billy W. Colston, Jr., Joseph P. Fitch, Benjamin J. Hindson, J. Chance Carter, Neil Reginald Beer
-
Patent number: 9422594Abstract: The invention is directed to methods of removing amplicons of non target and/or target nucleic acid sequences having one or more modified (e.g., methylated) nucleotides from a sample wherein the sample comprises the non target nucleic acid and a target nucleic acid sequence to be amplified.Type: GrantFiled: July 25, 2014Date of Patent: August 23, 2016Assignee: Courtagen Life Sciences, Inc.Inventor: Kevin J. McKernan
-
Patent number: 9410195Abstract: The present invention provides reagents for use in the amplification of nucleic acids. Amplification carried out using oligonucleotides containing modified nucleotides can result in less non-specific amplification compared to amplification carried out using unmodified oligonucleotides.Type: GrantFiled: July 17, 2015Date of Patent: August 9, 2016Assignee: ROCHE MOLECULAR SYSTEMS, INC.Inventors: Veeraiah Bodepudi, Nancy Schoenbrunner, Stephen Will
-
Patent number: 9404154Abstract: The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.Type: GrantFiled: August 13, 2014Date of Patent: August 2, 2016Assignee: Siemens Healthcare Diagnostics Inc.Inventors: Thomas Battersby, Toumy Guettouche, James Hnatyszyn
-
Patent number: 9404149Abstract: The present invention refers to a method for detecting a point mutations of a nucleotide sequence by an improvement of the LAMP (loop amplification mediated polymerization) amplification method, as well as to a set of primers and kit therefor. As a non limitative embodiment, the invention refers to the G1849T mutation of the JAK2 gene.Type: GrantFiled: June 8, 2010Date of Patent: August 2, 2016Assignee: BIOTRIN INTERNATIONAL LIMITEDInventors: Daniel Adlerstein, Giulia Amicarelli, Giulia Minnucci
-
Patent number: 9399761Abstract: The present invention relates in part to methods for producing tissue-specific cells from patient samples, and to tissue-specific cells produced using these methods. Methods for reprogramming cells using RNA are disclosed. Therapeutics comprising cells produced using these methods are also disclosed.Type: GrantFiled: July 27, 2015Date of Patent: July 26, 2016Assignee: FACTOR BIOSCIENCE INC.Inventors: Matthew Angel, Christopher Rohde
-
Patent number: 9394564Abstract: The present invention provides a method for amplifying a pool of polynucleotide molecules in a sample, characterized by the steps of a) obtaining a sample or RNA and reverse transcription of entire RNA molecules thus creating full length cDNA or obtaining a sample of full length cDNA, b) tailing the 3? end of the transcribed cDNA with a polynucleotide tail after the 3? end, c) amplification of the cDNA using a pair of primers, wherein a first 3? primer is specific for the 5? end of the cDNA and a second 5? primer is specific for the a upstream portion of the polynucleotide tail and the next 1 to 10 nucleotides upstream of the 3?polynucleotide tail of the cDNA.Type: GrantFiled: November 29, 2006Date of Patent: July 19, 2016Assignee: LEXOGEN GMBHInventor: Alexander Seitz
-
Patent number: 9394573Abstract: The present invention provides improved tests for the detection of methicillin-resistant Staphylococcus aureus bearing a variant mecA gene. The tests are particularly useful for eliminating certain false negative results due to the presence of this variant in MRSA in patient samples.Type: GrantFiled: December 21, 2012Date of Patent: July 19, 2016Assignee: bioMerieux S.A.Inventors: Francois Paillier, Celine Chambon, Cathy Saint-Patrice
-
Patent number: 9388473Abstract: This invention relates to a rapid method for detection of Salmonella in a sample based on the presence of nucleic acid sequences, in particular, to a PCR-based method for detection, and to oligonucleotide molecules and reagents and kits useful therefore. In certain embodiments, the method is employed to detect Salmonella in a food or water sample. The present invention further relates to isolated polynucleotides, replication compositions, and kits for carrying out the method of the present invention.Type: GrantFiled: November 7, 2012Date of Patent: July 12, 2016Assignee: E I DU PONT DE NEMOURS AND COMPANYInventors: Stephen Varkey, Daniel R. DeMarco
-
Patent number: 9388458Abstract: This invention provides methods, systems, and compositions for detecting low abundance microbial DNA in a sample by PCR. Methods of the present invention are based on a strategy that tags the 5?-end of the target DNA templates with a non-bacterial tagging sequence so as to set the templates apart from the endogenous contaminants present in the PCR reagents. There is also provided fusion probes for tagging the templates and primer sets to amplify the tagged templates. Systems and kits for facilitating and automating methods of the present invention are also provided.Type: GrantFiled: May 18, 2012Date of Patent: July 12, 2016Inventors: Ching-Ping Tseng, Shy-Shin Chang